Micro-cap stock below Rs 30 secures a USD 2.29 million grant from the Bill and Melinda Gates Foundation
Micro-cap stock below Rs 30 secures a USD 2.29 million grant from the Bill and Melinda Gates Foundation

Micro-cap stock below Rs 30 secures a USD 2.29 million grant from the Bill and Melinda Gates Foundation

Our upcoming participation in the manufacturing and distribution of this new platform highlights CoSara's commitment to the 'Make in India' initiative

Karan Dsij Article rating: 4.0

hese grants are earmarked for endeavors in the realm of Tuberculosis (TB) and Human Papillomavirus (HPV) tests on the innovative Co-DX PCR Home platform. The intention behind these grants is to enable the completion of these vital tests, geared toward vital global markets, where the prevalence of these conditions is pronounced.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR